An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus
(Q46625173)
scientific article published in May 2008
scientific article published in May 2008
Language:
Current Data About
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus